Marginum’s pioneering work to radically improve surgical outcomes has already led into technological breakthroughs and gained several academic and business awards. Our efforts will continue and all is set for a rapid market entry in 2024.
PAST
2016Basic Research
1/2019Draft Program
11/2020Founded
1/20211st Patent Application / Innovation Voucher
12/2021Pre-seed Funding
2/2022Research Grant (Runar Bäckström Foundation)
3/2022Research Award
4/2022Winner Startup
5/2022R&D Collaboration
7/2022Market validation / Tempo
8/20221st Major public project
10/2022Product preorders received
11/2022Prototype assemblies completed
12/2022 –Deep Tech Growth Program
Q4/2022Clinical Trials
FUTURE
Q1/20232nd Funding Round
Q1/2024Market entry to EU
Q3/2025Expansion to markets outside EU
Q4/2026Global leader in surgical tissue monitoring